UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease

Recruiting

Conditions: Congestive Heart Failure

First Posted Date: 2010-04-08

Last Posted Date: 2024-05-07

Lead Sponsor: University of Utah

Target Recruit Count: 300

Registration Number: NCT01099982

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States
🇺🇸
VA Salt Lake City Health Care System, Salt Lake City, Utah, United States
🇺🇸
Intermountain Medical Center, Murray, Utah, United States

Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis

Not Applicable

Terminated

Conditions: Psoriasis

Interventions: Drug: Acitretin 25Mg Oral Capsule
Device: Excimer laser
Device: Sham excimer laser
Drug: Tazarotene 0.1% Gel,Top

First Posted Date: 2010-03-29

Last Posted Date: 2019-06-26

Lead Sponsor: University of Utah

Target Recruit Count: 13

Registration Number: NCT01094717

Locations: 🇺🇸
University of Utah Department of Dermatology, Salt Lake City, Utah, United States

Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer

Phase 1

Terminated

Conditions: Stages II-III Breast Cancer

Interventions: Drug: Nanoparticle Albumin Bound Paclitaxel
Drug: doxorubicin
Drug: cyclophosphamide

First Posted Date: 2010-03-19

Last Posted Date: 2017-03-31

Lead Sponsor: University of Utah

Target Recruit Count: 27

Registration Number: NCT01090128

Locations: 🇺🇸
University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, United States

Reducing Falls With RENEW in Older Adults Who Have Fallen

Not Applicable

Completed

Conditions: Muscle Atrophy
Physical Deconditioning

Interventions: Behavioral: RENEW

First Posted Date: 2010-03-03

Last Posted Date: 2022-06-21

Lead Sponsor: University of Utah

Target Recruit Count: 134

Registration Number: NCT01080196

Locations: 🇺🇸
Department of Physical Therapy, University of Utah, Salt Lake City, Utah, United States

Nickel Allergy With Septal Closure Devices

Terminated

Conditions: Atrial Septal Defect
Patent Foramen Ovale
Allergic Reaction to Nickel

First Posted Date: 2010-02-12

Last Posted Date: 2013-05-15

Lead Sponsor: University of Utah

Target Recruit Count: 4

Registration Number: NCT01068366

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Pilot Study of the Safety and Efficacy of Oxandrolone in the Prevention and Treatment of Malnutrition in Infants

Phase 1

Completed

Conditions: Malnutrition

Interventions: Drug: Oxandrolone

First Posted Date: 2010-01-13

Last Posted Date: 2020-01-29

Lead Sponsor: University of Utah

Target Recruit Count: 20

Registration Number: NCT01048632

Locations: 🇺🇸
Primary Childrens Hospital, Salt Lake City, Utah, United States

RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma

Phase 1

Completed

Conditions: Colorectal Cancer

Interventions: Drug: RAD001
Drug: FOLFOX
Drug: Bevacizumab

First Posted Date: 2010-01-12

Last Posted Date: 2017-04-04

Lead Sponsor: University of Utah

Target Recruit Count: 47

Registration Number: NCT01047293

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸
Utah Cancer Specialists, Salt Lake City, Utah, United States

Etanercept for the Treatment of Chronic Urticaria

Phase 2

Withdrawn

Conditions: Chronic Idiopathic Urticaria

Interventions: Drug: placebo
Drug: etanercept

First Posted Date: 2009-12-11

Last Posted Date: 2015-06-02

Lead Sponsor: University of Utah

Registration Number: NCT01030120

Locations: 🇺🇸
University of Utah Department of Dermatology, Salt Lake City, Utah, United States

Study of Trilipix Effects on Lipids and Arteries

Phase 4

Terminated

Conditions: Dyslipidemia

Interventions: Drug: placebo
Drug: Trilipix

First Posted Date: 2009-12-03

Last Posted Date: 2016-09-01

Lead Sponsor: University of Utah

Target Recruit Count: 24

Registration Number: NCT01025492

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Validating Interventions for Diverse Adolescents

Phase 2

Completed

Conditions: Substance-Related Disorders

Interventions: Behavioral: Standard Cognitive Behavioral Treatment
Behavioral: Culturally Adapted Cognitive-Behavioral Treatment

First Posted Date: 2009-11-25

Last Posted Date: 2023-04-18

Lead Sponsor: University of Utah

Target Recruit Count: 70

Registration Number: NCT01018654

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy